ABALX
ABALX
American Funds American Balanced AIncome Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2023 | $187.61M ▼ | $1.74M ▼ | $20.57M ▼ | 10.96% ▼ | $1.17 ▼ | $27.45M ▼ |
| Q3-2023 | $221.08M ▲ | $2.87M ▼ | $26.08M ▲ | 11.79% ▲ | $1.49 ▲ | $36.14M ▲ |
| Q2-2023 | $211.98M ▼ | $5.57M ▼ | $9.05M ▲ | 4.27% ▲ | $0.52 ▲ | $14.23M ▲ |
| Q1-2023 | $212.71M ▲ | $9.14M ▲ | $5.24M ▼ | 2.46% ▼ | $0.3 ▼ | $8.82M ▼ |
| Q4-2022 | $200.17M | $2.6M | $8.16M | 4.08% | $0.47 | $12.65M |
What's going well?
The company remains profitable and has no debt burden. Operating expenses were trimmed, and earnings are clean without one-time charges.
What's concerning?
Revenue and profits dropped sharply, and margins are getting squeezed. The business appears low-margin and vulnerable to further declines if sales keep falling.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2023 | $378.66M ▲ | $664.8M ▲ | $77.2M ▲ | $513.92M ▲ |
| Q3-2023 | $332M ▲ | $627.56M ▲ | $62.02M ▲ | $492.99M ▲ |
| Q2-2023 | $284.38M ▲ | $592.94M ▲ | $59.39M ▲ | $466.56M ▲ |
| Q1-2023 | $265.81M ▼ | $566.54M ▼ | $49.14M ▼ | $453.64M ▲ |
| Q4-2022 | $280.94M | $579.58M | $68.58M | $447.98M |
What's financially strong about this company?
The company has a huge cash pile, very little debt, and most assets are real and easy to value. Liquidity is excellent, and equity keeps growing, showing ongoing profitability.
What are the financial risks or weaknesses?
There are few risks—one minor concern is that payables are rising, which could mean they're delaying payments. Also, the drop in investments could mean less income from that source.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2023 | $20.57M ▼ | $60.78M ▲ | $91.67M ▲ | $-3.61M ▼ | $148.84M ▲ | $45.47M ▲ |
| Q3-2023 | $26.08M ▲ | $58.55M ▲ | $-88.17M ▼ | $0 | $-29.62M ▼ | $44.37M ▲ |
| Q2-2023 | $9.05M ▲ | $19.26M ▲ | $3.87M ▼ | $0 ▲ | $23.13M ▲ | $15.29M ▲ |
| Q1-2023 | $5.24M ▼ | $-10.63M ▼ | $21.04M ▲ | $-716K ▲ | $9.7M ▲ | $-14.83M ▼ |
| Q4-2022 | $8.16M | $801K | $-64.48M | $-2.27M | $-65.95M | $-7.59M |
What's strong about this company's cash flow?
ABALX generates more cash than it reports as profit, with $60.8 million in operating cash flow and $45.5 million in free cash flow this quarter. Cash is growing fast, and the company doesn't rely on outside funding.
What are the cash flow concerns?
Net income dropped this quarter, and the big cash increase was helped by one-time investing activity. Working capital changes may not repeat, and no cash is being returned to shareholders.
5-Year Trend Analysis
A comprehensive look at American Funds American Balanced A's financial evolution and strategic trajectory over the past five years.
ABALX combines solid current profitability, strong conversion of earnings into cash, and a very conservative balance sheet with ample liquidity and minimal debt. It sits within a highly reputable, research‑driven asset manager that uses a multi‑manager system, deep analyst resources, and long‑term discipline. Its long history, strong brand, and significant scale in the balanced‑fund space further support its position.
Key risks include the lack of multi‑year financial detail in this data set, making it difficult to assess how resilient profitability and cash flow are across market cycles. As an actively managed balanced fund, it faces intense competition and fee pressure from index products and alternative allocation solutions. The absence of explicit R&D spending on the statements, reliance on market performance of underlying holdings, potential leadership changes, and evolving regulation all represent ongoing uncertainties.
Based on the information available, ABALX appears financially sound and operationally disciplined, with a well‑established competitive position supported by a strong parent organization and continuous process‑focused innovation. Its future will depend on how effectively it maintains investment discipline, adapts to industry fee and regulatory pressures, and leverages its research and technology investments. Outcomes for investors will ultimately be driven by market conditions and execution, rather than by balance‑sheet strength alone.
About American Funds American Balanced A
https://www.capitalgroup.comThe fund uses a balanced approach to invest in a broad range of securities, including common stocks and investment-grade bonds. It also invests in securities issued and guaranteed by the U.S. government and by federal agencies and instrumentalities.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2023 | $187.61M ▼ | $1.74M ▼ | $20.57M ▼ | 10.96% ▼ | $1.17 ▼ | $27.45M ▼ |
| Q3-2023 | $221.08M ▲ | $2.87M ▼ | $26.08M ▲ | 11.79% ▲ | $1.49 ▲ | $36.14M ▲ |
| Q2-2023 | $211.98M ▼ | $5.57M ▼ | $9.05M ▲ | 4.27% ▲ | $0.52 ▲ | $14.23M ▲ |
| Q1-2023 | $212.71M ▲ | $9.14M ▲ | $5.24M ▼ | 2.46% ▼ | $0.3 ▼ | $8.82M ▼ |
| Q4-2022 | $200.17M | $2.6M | $8.16M | 4.08% | $0.47 | $12.65M |
What's going well?
The company remains profitable and has no debt burden. Operating expenses were trimmed, and earnings are clean without one-time charges.
What's concerning?
Revenue and profits dropped sharply, and margins are getting squeezed. The business appears low-margin and vulnerable to further declines if sales keep falling.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2023 | $378.66M ▲ | $664.8M ▲ | $77.2M ▲ | $513.92M ▲ |
| Q3-2023 | $332M ▲ | $627.56M ▲ | $62.02M ▲ | $492.99M ▲ |
| Q2-2023 | $284.38M ▲ | $592.94M ▲ | $59.39M ▲ | $466.56M ▲ |
| Q1-2023 | $265.81M ▼ | $566.54M ▼ | $49.14M ▼ | $453.64M ▲ |
| Q4-2022 | $280.94M | $579.58M | $68.58M | $447.98M |
What's financially strong about this company?
The company has a huge cash pile, very little debt, and most assets are real and easy to value. Liquidity is excellent, and equity keeps growing, showing ongoing profitability.
What are the financial risks or weaknesses?
There are few risks—one minor concern is that payables are rising, which could mean they're delaying payments. Also, the drop in investments could mean less income from that source.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2023 | $20.57M ▼ | $60.78M ▲ | $91.67M ▲ | $-3.61M ▼ | $148.84M ▲ | $45.47M ▲ |
| Q3-2023 | $26.08M ▲ | $58.55M ▲ | $-88.17M ▼ | $0 | $-29.62M ▼ | $44.37M ▲ |
| Q2-2023 | $9.05M ▲ | $19.26M ▲ | $3.87M ▼ | $0 ▲ | $23.13M ▲ | $15.29M ▲ |
| Q1-2023 | $5.24M ▼ | $-10.63M ▼ | $21.04M ▲ | $-716K ▲ | $9.7M ▲ | $-14.83M ▼ |
| Q4-2022 | $8.16M | $801K | $-64.48M | $-2.27M | $-65.95M | $-7.59M |
What's strong about this company's cash flow?
ABALX generates more cash than it reports as profit, with $60.8 million in operating cash flow and $45.5 million in free cash flow this quarter. Cash is growing fast, and the company doesn't rely on outside funding.
What are the cash flow concerns?
Net income dropped this quarter, and the big cash increase was helped by one-time investing activity. Working capital changes may not repeat, and no cash is being returned to shareholders.
5-Year Trend Analysis
A comprehensive look at American Funds American Balanced A's financial evolution and strategic trajectory over the past five years.
ABALX combines solid current profitability, strong conversion of earnings into cash, and a very conservative balance sheet with ample liquidity and minimal debt. It sits within a highly reputable, research‑driven asset manager that uses a multi‑manager system, deep analyst resources, and long‑term discipline. Its long history, strong brand, and significant scale in the balanced‑fund space further support its position.
Key risks include the lack of multi‑year financial detail in this data set, making it difficult to assess how resilient profitability and cash flow are across market cycles. As an actively managed balanced fund, it faces intense competition and fee pressure from index products and alternative allocation solutions. The absence of explicit R&D spending on the statements, reliance on market performance of underlying holdings, potential leadership changes, and evolving regulation all represent ongoing uncertainties.
Based on the information available, ABALX appears financially sound and operationally disciplined, with a well‑established competitive position supported by a strong parent organization and continuous process‑focused innovation. Its future will depend on how effectively it maintains investment discipline, adapts to industry fee and regulatory pressures, and leverages its research and technology investments. Outcomes for investors will ultimately be driven by market conditions and execution, rather than by balance‑sheet strength alone.

CEO

